步长制药(603858.SH)：泸州步长拟与马来西亚公司MEDISPEC签署《独家供应协议》

Core Viewpoint - The company, Buchang Pharma (603858.SH), announced that its subsidiary, Luzhou Buchang, plans to sign an exclusive supply agreement with Malaysian company MEDISPEC for the registration, promotion, distribution, and sales of injectable Efparepoetin alfa in the target region [1] Group 1 - The agreement will grant MEDISPEC exclusive agency rights in the specified target area [1] - The focus of the agreement is on the injectable form of Efparepoetin alfa, which is a pharmaceutical product [1]